Skip to search formSkip to main contentSkip to account menu

Botulinum Toxins

Known as: Botulinum Toxins [Chemical/Ingredient], Botulin, Toxin, Botulinum 
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature… 
National Institutes of Health

Related topics

Related topics

36 relations

Broader (3)

Bacterial ToxinsBacterial exotoxinExotoxins

Narrower (8)

BotoxBotulinum Toxin Type AMyoblocSXN101959
BotulismCholinergic AgentsClostridium botulinumClostridium botulinum toxin A Ab:PrThr:Pt:Ser:Ord

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
PURPOSE We determined the safety and efficacy of each of 2 doses of botulinum toxin type A (BTX-A) (200 or 300 U BOTOX) injected… 
Highly Cited
2005
Highly Cited
2005
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by… 
Review
2004
Review
2004
Development of resistance to botulinum toxin type A in patients with torticollis
Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of… 
Review
2004
Review
2004
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
The use of botulinum toxin type A for facial enhancement is the most common cosmetic procedure currently undertaken in the United… 
Highly Cited
2003
Highly Cited
2003
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
The authors compared 130 patients treated for cervical dystonia with original botulinum toxin (BTX) type A (Botox; Allergan, Inc… 
Highly Cited
1994
Highly Cited
1994
Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections
Fiber diameter variability, acetylcholinesterase staining properties, and average fiber diameter were determined 5 weeks after… 
Highly Cited
1990
Highly Cited
1990
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
In the past five years, 477 patients with various focal dystonias and hemifacial spasm received 3,806 injections of botulinum A… 
Highly Cited
1989
Highly Cited
1989
rac, a novel ras-related family of proteins that are botulinum toxin substrates.
A new family of ras-related proteins, designated rac (ras-related C3 botulinum toxin substrate) has been identified. rac1 and… 
Review
1986
Review
1986
Molecular pharmacology of botulinum toxin and tetanus toxin.
Botulinum toxin is a term that has been used to describe eight different substances designated types A, B, Cb C2, D, E, F, and G… 
Highly Cited
1949
Highly Cited
1949
The action of botulinum toxin on the neuro‐muscular junction
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)